DSC Advisors, L.P. - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 228 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.

Quarter-by-quarter ownership
DSC Advisors, L.P. ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$2,307,000
-0.4%
82,500
+26.9%
1.37%
+13.2%
Q4 2015$2,317,000
-22.1%
65,000
-27.8%
1.21%
-16.3%
Q3 2015$2,976,000
+9.3%
90,000
+38.5%
1.44%
+2.0%
Q2 2015$2,722,000
+28.5%
65,0000.0%1.42%
+26.0%
Q1 2015$2,118,00065,0001.12%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Sio Capital Management, LLC 563,200$16,243,0009.48%
Avoro Capital Advisors LLC 1,486,460$42,870,0008.66%
Baker Brothers Advisors 25,819,768$744,642,0007.30%
SECTORAL ASSET MANAGEMENT INC 1,176,543$33,932,0003.76%
HARVEY CAPITAL MANAGEMENT INC 251,825$7,262,0003.38%
ACUTA CAPITAL PARTNERS, LLC 300,000$8,652,0003.22%
Palo Alto Investors LP 1,532,030$44,184,0002.52%
Ghost Tree Capital, LLC 350,000$10,094,0002.43%
EMORY UNIVERSITY 76,121$2,195,0002.16%
WEATHERBIE CAPITAL, LLC 576,784$16,634,0002.09%
View complete list of ACADIA PHARMACEUTICALS INC shareholders